Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

NCT00019019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Breast Cancer
Kidney Cancer
Lung Cancer
Lymphoma
Melanoma (Skin)
Ovarian Cancer
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: carboxyamidotriazole
DRUG: paclitaxel

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]